BAP:NYSECredicorp Ltd. Analysis
Data as of 2026-03-10 - not real-time
$340.87
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Credicorp Ltd. (BAP) shows a technically bullish backdrop as the short‑term moving average remains above the longer‑term averages, supporting upward momentum, while the RSI hovers around the midpoint, indicating no immediate overbought pressure. However, the MACD has turned bearish and trading volume is on a downtrend, suggesting a potential short‑term pullback despite the broader bullish trend. Fundamentally, the stock trades at a price‑to‑earnings multiple comfortably below the industry average, offers a solid dividend yield with a payout ratio under 50%, and delivers strong operating margins and return on equity, all of which point to attractive value. Yet, operating cash flow is negative and the company flags a material currency headwind from Bolivia, which could temper earnings growth and dividend sustainability.
The consensus analyst outlook remains positive, with a “buy” recommendation and target prices modestly above the current level, while the market sentiment index reflects “extreme greed,” indicating bullish investor appetite. In this context, the stock appears fairly priced with limited upside, making a cautious hold in the near term prudent, but the underlying fundamentals and dividend profile support a buy stance for medium to long horizons, provided investors monitor liquidity and currency exposures.
The consensus analyst outlook remains positive, with a “buy” recommendation and target prices modestly above the current level, while the market sentiment index reflects “extreme greed,” indicating bullish investor appetite. In this context, the stock appears fairly priced with limited upside, making a cautious hold in the near term prudent, but the underlying fundamentals and dividend profile support a buy stance for medium to long horizons, provided investors monitor liquidity and currency exposures.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD divergence
- Decreasing trading volume
- Recent earnings miss versus consensus
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Valuation discount to industry peers
- Attractive dividend yield with sustainable payout
- Management focus on cost‑to‑income improvements
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong return on equity and operating margins
- Diversified regional footprint with growth potential
- Robust cash reserves offsetting net debt
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin33.46%
P/E Ratio13.8
ROE19.12%
ROA2.71%
P/B Ratio2.5
Op. Cash Flow$-8641963008
Industry P/E17.3
Technical Analysis
TrendBullish
RSI50.4
Support$318.15
Resistance$360.83
MA 20$342.79
MA 50$333.39
MA 200$269.45
MACDBearish
VolumeDecreasing
Fear & Greed Index76.55
Valuation
Target Price$344.21
Upside/Downside0.98%
GradeUndervalued
TypeBlend
Dividend Yield3.34%
Risk Assessment
Beta0.60
Volatility36.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.